Search Results - "DANKS, M. K"

Refine Results
  1. 1
  2. 2

    Stem and progenitor cell-mediated tumor selective gene therapy by Aboody, K S, Najbauer, J, Danks, M K

    Published in Gene therapy (01-05-2008)
    “…The poor prognosis for patients with aggressive or metastatic tumors and the toxic side effects of currently available treatments necessitate the development…”
    Get full text
    Journal Article
  3. 3

    Proficient metabolism of irinotecan by a human intestinal carboxylesterase by KHANNA, Ruchi, MORTON, Christopher L, DANKS, Mary K, POTTER, Philip M

    Published in Cancer research (Chicago, Ill.) (01-09-2000)
    “…Irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)] is metabolized by esterases to yield the potent topoisomerase I poison…”
    Get full text
    Journal Article
  4. 4

    Activation of CPT-11 in mice : Identification and analysis of a highly effective plasma esterase by MORTON, C. L, WIERDL, M, OLIVER, L, MA, M. K, DANKS, M. K, STEWART, C. F, EISEMAN, J. L, POTTER, P. M

    Published in Cancer research (Chicago, Ill.) (01-08-2000)
    “…The camptothecin prodrug CPT-11 (irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin) is converted by esterases to yield the potent…”
    Get full text
    Journal Article
  5. 5

    Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors by HOUGHTON, P. J, CHESHIRE, P. J, HALLMAN, J. D, LUTZ, L, FRIEDMAN, H. S, DANKS, M. K, HOUGHTON, J. A

    Published in Cancer chemotherapy and pharmacology (01-09-1995)
    “…The efficacy of protracted schedules of therapy of the topoisomerase I inhibitors 9-dimethyl-aminomethyl-10-hydroxycamptothecin (topotecan) and…”
    Get full text
    Journal Article
  6. 6

    The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase by MORTON, C. L, WADKINS, R. M, DANKS, M. K, POTTER, P. M

    Published in Cancer research (Chicago, Ill.) (01-04-1999)
    “…Patients treated with high doses of CPT-11 rapidly develop a cholinergic syndrome that can be alleviated by atropine. Although CPT-11 was not a substrate for…”
    Get full text
    Journal Article
  7. 7

    Sensitization of human tumor cells to CPT-11 via adenoviral-mediated delivery of a rabbit liver carboxylesterase by WIERDL, Monika, MORTON, Christopher L, WEEKS, James K, DANKS, Mary K, HARRIS, Linda C, POTTER, Philip M

    Published in Cancer research (Chicago, Ill.) (01-07-2001)
    “…Irinotecan, 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) is activated by carboxylesterases (CE) to yield the potent topoisomerase…”
    Get full text
    Journal Article
  8. 8

    Comparison of Activation of CPT-11 by Rabbit and Human Carboxylesterases for Use in Enzyme/Prodrug Therapy by DANKS, M. K, MORTON, C. L, KRULL, E. J, CHESHIRE, P. J, RICHMOND, L. B, NAEVE, C. W, PAWLIK, C. A, HOUGHTON, P. J, POTTER, P. M

    Published in Clinical cancer research (01-04-1999)
    “…Several recent studies have examined the possibility of producing tumor-specific cytotoxicity with various enzyme/prodrug combinations. The enzymes are…”
    Get full text
    Journal Article
  9. 9

    Expression of a Mutant DNA Topoisomerase II in CCRF-CEM Human Leukemic Cells Selected for Resistance to Teniposide by BUGG, B. Y, DANKS, M. K, BECK, W. T, PARKER SUTTLE, D

    “…Nuclear extracts from teniposide (VM-26)-resistant sublines of the human leukemic cell line CCRF-CEM have decreased levels of DNA topoisomerase II catalytic…”
    Get full text
    Journal Article
  10. 10

    Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11) by POTTER, P. M, PAWLIK, C. A, MORTON, C. L, NAEVE, C. W, DANKS, M. K

    Published in Cancer research (Chicago, Ill.) (15-06-1998)
    “…We have isolated a cDNA encoding a rabbit carboxylesterase (CE; EC 3.1.1.1) that converts the camptothecin-derived prodrug irinotecan (CPT-11) to the potent…”
    Get full text
    Journal Article
  11. 11

    Overexpression of a rabbit liver carboxylesterase sensitizes human tumor cells to CPT-11 by DANKS, M. K, MORTON, C. L, PAWLIK, C. A, POTTER, P. M

    Published in Cancer research (Chicago, Ill.) (1998)
    “…CPT-11 [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin ] is a prodrug that is converted to the active metabolite SN-38 by carboxylesterases…”
    Get full text
    Journal Article
  12. 12

    Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase by GUICHARD, S. M, MORTON, C. L, KRULL, E. J, STEWART, C. F, DANKS, M. K, POTTER, P. M

    Published in Clinical cancer research (01-12-1998)
    “…The anticancer drug CPT-11 (7-ethyl-[4(1-piperidino)-1-piperidino]carbonyloxycamptothecin) is a water-soluble derivative of camptothecin. We report here the…”
    Get full text
    Journal Article
  13. 13

    Cellular localization domains of a rabbit and a human carboxylesterase : Influence on irinotecan (CPT-11) metabolism by the rabbit enzyme by POTTER, P. M, WOLVERTON, J. S, MORTON, C. L, WIERDL, M, DANKS, M. K

    Published in Cancer research (Chicago, Ill.) (15-08-1998)
    “…Enzyme activation of prodrugs to improve the therapeutic index of specific anticancer agents is an attractive alternative to current chemotherapy regimens…”
    Get full text
    Journal Article
  14. 14

    Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays by PAWLIK, C. A, HOUGHTON, P. J, STEWART, C. F, CHESHIRE, P. J, RICHMOND, L. B, DANKS, M. K

    Published in Clinical cancer research (01-08-1998)
    “…The camptothecin derivative topotecan has been postulated to mediate its antitumor effect through a drug-induced increase in covalent topoisomerase I-DNA…”
    Get full text
    Journal Article
  15. 15

    A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11 by MECK, Mandy M, WIERDL, Monika, WAGNER, Lars M, BURGER, Rebecca A, GUICHARD, Sylvie M, KRULL, Erik J, HARRIS, Linda C, POTTER, Philip M, DANKS, Mary K

    Published in Cancer research (Chicago, Ill.) (01-07-2001)
    “…Tumor cells that contaminate hematopoietic cell preparations contribute to the relapse of neuroblastoma patients who receive autologous stem cell rescue as a…”
    Get full text
    Journal Article
  16. 16

    Intermittent exposure of medulloblastoma cells to topotecan produces growth inhibition equivalent to continuous exposure by DANKS, M. K, PAWLIK, C. A, WHIPPLE, D. O, WOLVERTON, J. S

    Published in Clinical cancer research (01-10-1997)
    “…Camptothecin analogues such as topotecan increase the number of covalent topoisomerase I-DNA complexes, which, in turn, have been proposed to initiate…”
    Get full text
    Journal Article
  17. 17

    Subcellular redistribution of DNA topoisomerase I in anaplastic astrocytoma cells treated with topotecan by DANKS, M. K, GARRETT, K. E, MARION, R. C, WHIPPLE, D. O

    Published in Cancer research (Chicago, Ill.) (01-04-1996)
    “…DNA topoisomerase I is the cytotoxic target for chemotherapeutic agents of the camptothecin class. The cytotoxicity of these drugs is thought to be mediated by…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Decreased drug accumulation in a mitoxantrone‐resistant gastric carcinoma cell line in the absence of P‐glycoprotein by Kellner, Udo, Hutchinson, Lesley, Seidel, André, Lage, Hermann, Danks, Mary K., Dietel, Manfred, Kaufmann, Scott H.

    Published in International journal of cancer (29-05-1997)
    “…An established gastric‐carcinoma cell line, EPG85‐257P, is extremely sensitive to mitoxantrone (IC50, 0.12 ng/ml). Stepwise selection with mitoxantrone for 3…”
    Get full text
    Journal Article
  20. 20